While patients themselves may not know the source of their compounded drug, 503A vs 503B pharmacies have a direct effect on ...

A letter from HHS Secretary Robert F Kennedy Jr. and FDA Commissioner Martin Makary, in which they confirmed that the FDA is ...

After all the threats, it seems President Trump's tariffs on pharmaceuticals are coming to fruition, and a lot sooner than ...

The drug – which will be sold in the US under the Inluriyo trade name – is only the second drug in the oral SERD category to ...

All of the DTC channels offer discounts for people willing and able to pay for medicines with cash, and that also applies to Sotyktu (deucravacitinib), which, from January, will be available at a ...

Earlier this year, PTC Therapeutics and Novartis' experimental therapy for Huntington's, mRNA splicing modifier PTC518 ...

According to a head-to-head trial called DEVOTE, which underpins the application, the high-dose of nusinersen slowed ...

Investors in Verona – a specialist in respiratory medicines – overwhelmingly gave their blessing to MSD's $107-per-share ...

The San Diego-based company claims a number of firsts for its coin-sized Biolinq Shine device, including that it is so far ...

Roche has staked a claim to use its oral selective oestrogen receptor degrader (SERD) giredestrant as a second-line therapy ...

Merck KGaA's chief executive Belén Garijo will end her time at the helm of the company next April, five years after taking ...

The first patient has already been treated with bemdaneprocel, a one-shot treatment designed to replace the ...